122 related articles for article (PubMed ID: 17241787)
1. Synthesis and evaluation as MRI probe of the trifluoromethylated p-boronophenylalanine and its alcohol derivative.
Hattori Y; Yamamoto H; Ando H; Kondoh H; Asano T; Kirihata M; Yamaguchi Y; Wakamiya T
Bioorg Med Chem; 2007 Mar; 15(5):2198-205. PubMed ID: 17241787
[TBL] [Abstract][Full Text] [Related]
2. Study on the compounds containing 19F and 10B atoms in a single molecule for the application to MRI and BNCT.
Hattori Y; Asano T; Niki Y; Kondoh H; Kirihata M; Yamaguchi Y; Wakamiya T
Bioorg Med Chem; 2006 May; 14(10):3258-62. PubMed ID: 16460951
[TBL] [Abstract][Full Text] [Related]
3. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields.
Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B
Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868
[TBL] [Abstract][Full Text] [Related]
4. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT.
Shirakawa M; Yamamto T; Nakai K; Aburai K; Kawatobi S; Tsurubuchi T; Yamamoto Y; Yokoyama Y; Okuno H; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S88-90. PubMed ID: 19446462
[TBL] [Abstract][Full Text] [Related]
6. Biomedical applications of 10B and 11B NMR.
Bendel P
NMR Biomed; 2005 Apr; 18(2):74-82. PubMed ID: 15770608
[TBL] [Abstract][Full Text] [Related]
7. Biological evaluation of fluorinated p-boronophenylalanine derivatives as a boron carrier.
Hattori Y; Kurihara K; Kondoh H; Asano T; Kirihata M; Yamaguchi Y; Wakamiya T
Protein Pept Lett; 2007; 14(3):269-72. PubMed ID: 17346232
[TBL] [Abstract][Full Text] [Related]
8. T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy.
Yamamoto Y; Isobe T; Yamamoto T; Shibata Y; Anno I; Nakai K; Shirakawa M; Matsushita A; Sato E; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S345-7. PubMed ID: 19406648
[TBL] [Abstract][Full Text] [Related]
9. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
[TBL] [Abstract][Full Text] [Related]
10. In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Migneco LM; Campanella R; Maraviglia B; Pastore FS
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924
[TBL] [Abstract][Full Text] [Related]
11. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA
Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900
[TBL] [Abstract][Full Text] [Related]
12. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
13. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S
Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888
[TBL] [Abstract][Full Text] [Related]
14. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of oligonucleoside boranophosphates via an H-phosphonate method without nucleobase protection.
Sergueev DS; Sergueeva ZA; Shaw BR
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):789-95. PubMed ID: 11563117
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo biodistribution of BPA-Gd-DTPA complex as a potential MRI contrast carrier for neutron capture therapy.
Takahashi K; Nakamura H; Furumoto S; Yamamoto K; Fukuda H; Matsumura A; Yamamoto Y
Bioorg Med Chem; 2005 Feb; 13(3):735-43. PubMed ID: 15653341
[TBL] [Abstract][Full Text] [Related]
17. Catalytic asymmetric synthesis of α-methyl-p-boronophenylalanine.
Harada S; Kajihara R; Muramoto R; Jutabha P; Anzai N; Nemoto T
Bioorg Med Chem Lett; 2018 Jun; 28(10):1915-1918. PubMed ID: 29655983
[TBL] [Abstract][Full Text] [Related]
18. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.
Yoshino K; Suzuki A; Mori Y; Kakihana H; Honda C; Mishima Y; Kobayashi T; Kanda K
Strahlenther Onkol; 1989; 165(2-3):127-9. PubMed ID: 2928932
[No Abstract] [Full Text] [Related]
19. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
20. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
